Angiotensin-Converting Enzyme and Hypertension: A Systemic Analysis of Various ACE Inhibitors, Their Side Effects, and Bioactive Peptides as a Putative Therapy for Hypertension
Journal of the Renin-Angiotensin-Aldosterone System · 2023-01 · 2023
DOI: 10.1155/2023/7890188 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of the Renin-Angiotensin-Aldosterone System, online erschienen am 21.06.2023. Verfasst von Hafiz Ahmad und 5 weiteren Autor:innen. Beteiligte Einrichtung: RAK College of Medical Sciences, RAK Medical & Health Sciences University, Ras al Khaimah, UAE. Hauptthemen laut MEDLINE: Angiotensin-Converting Enzyme Inhibitors, Hypertension. Die Arbeit wurde bisher 127-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: RAK Medical and Health Sciences University, Shoolini University, Feinstein Institutes for Medical Research.
Abstract (Originalsprache)
Hypertension is a major risk factor for heart attack, produce atherosclerosis (hardening of the arteries), congestive heart failure, stroke, kidney infection, blindness, end-stage renal infection, and cardiovascular diseases. Many mechanisms are involved in causing hypertension, i.e., via calcium channels, alpha and beta receptors, and the renin-angiotensin system (RAS). RAS has an important role in blood pressure control and is also involved in the metabolism of glucose, homeostasis, and balance of electrolytes in the body. The components of RAS that are involved in the regulation of blood pressure are angiotensinogen, Ang I (angiotensin I), Ang II (angiotensin II), ACE (angiotensin-converting enzyme), and ACE 2 (angiotensin-converting enzyme 2). These components provide for relevant therapeutic targets for the treatment of hypertension, and various drugs are commercially available that target individual components of RAS. Angiotensin receptor blockers (ARBs) and ACE inhibitors are the most popular among these drugs. ACE is chosen in this review as it makes an important target for blood pressure control because it converts Ang I into Ang II and also acts on the vasodilator, bradykinin, to degrade it into inactive peptides. This review highlights various aspects of blood pressure regulation in the body with a focus on ACE, drugs targeting the components involved in regulation, their associated side effects, and a need to shift to alternative therapy for putative hypertension treatment in the form of bioactive peptides from food.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- RAK College of Medical Sciences, RAK Medical & Health Sciences University, Ras al Khaimah, UAE.
- Microbiology and Molecular Division-RAK Hospital, Ras al Khaimah, UAE.
- Faculty of Biotechnology and Applied Sciences, Shoolini University of Biotechnology and Management Sciences, Solan, India.
- The Feinstein Institute of Medical Research, Northwell Health, Manhasset, NY, USA.
- Department of Orthopedics, Lady Hardinge Medical College, New Delhi, India.
ORCID-Profile: Hafiz Ahmad, Huma Khan, Shabirul Haque, Shameem Ahmad, Namita Srivastava, Azhar Khan
Förderung
- RAK Medical and Health Sciences University
- Shoolini University
- Feinstein Institutes for Medical Research
Zitieren
APA
Ahmad, H., Khan, H., Haque, S., Ahmad, S., Srivastava, N., & Khan, A. (2023). Angiotensin-Converting Enzyme and Hypertension: A Systemic Analysis of Various ACE Inhibitors, Their Side Effects, and Bioactive Peptides as a Putative Therapy for Hypertension. Journal of the Renin-Angiotensin-Aldosterone System, 2023. https://doi.org/10.1155/2023/7890188
Vancouver
Ahmad H, Khan H, Haque S, Ahmad S, Srivastava N, Khan A. Angiotensin-Converting Enzyme and Hypertension: A Systemic Analysis of Various ACE Inhibitors, Their Side Effects, and Bioactive Peptides as a Putative Therapy for Hypertension. Journal of the Renin-Angiotensin-Aldosterone System. 2023;2023. doi:10.1155/2023/7890188
BibTeX
@article{Ahmad2023,
author = {Ahmad, Hafiz and Khan, Huma and Haque, Shabirul and Ahmad, Shameem and Srivastava, Namita and Khan, Azhar},
title = {Angiotensin-Converting Enzyme and Hypertension: A Systemic Analysis of Various ACE Inhibitors, Their Side Effects, and Bioactive Peptides as a Putative Therapy for Hypertension},
journal = {Journal of the Renin-Angiotensin-Aldosterone System},
year = {2023},
volume = {2023},
doi = {10.1155/2023/7890188}
}
EUVIMED